MH
Therapeutic Areas
Advanced NanoTherapies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SirPlux Duo DCB | Coronary Artery Disease (CAD) | Pre-clinical |
| Single-drug DCB Platform (Paclitaxel) | Vascular Disease (Proof-of-Concept) | Pre-clinical |
| Single-drug DCB Platform (Sirolimus) | Vascular Disease (Proof-of-Concept) | Pre-clinical |
Leadership Team at Advanced NanoTherapies
MB
Marwan Berrada
Chief Executive Officer
MM
Michael Mandel
Head of Corporate Development
VL
Vinod Labhasetwar
Scientific Advisor
FP
Frank Proch
Vice President, R&D
AM
Angela Mallery
Vice President, Regulatory Affairs & Quality Assurance
JG
Joey Groszek
Director, Nanoparticle R&D
PM
Paul McFeely
Senior Manager, Quality Assurance
AL
Azeem Latib
Scientific Advisory Board Member
GA
Gary Ansel
Scientific Advisory Board Member
PS
Peter Schneider
Scientific Advisory Board Member